Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma

Podobne zapisy

• Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
  od: D’Ambrosio, Roberta, i wsp.
  Wydane: (2021)
• Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
  od: Lee, Chang Hun, i wsp.
  Wydane: (2021)
• Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
  od: Chen-Ta Chi, i wsp.
  Wydane: (2021-06-01)
• Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
  od: Imai, Kenji, i wsp.
  Wydane: (2020)
• Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
  od: Kamp, William M., i wsp.
  Wydane: (2019)